JPWO2021026130A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021026130A5 JPWO2021026130A5 JP2022507374A JP2022507374A JPWO2021026130A5 JP WO2021026130 A5 JPWO2021026130 A5 JP WO2021026130A5 JP 2022507374 A JP2022507374 A JP 2022507374A JP 2022507374 A JP2022507374 A JP 2022507374A JP WO2021026130 A5 JPWO2021026130 A5 JP WO2021026130A5
- Authority
- JP
- Japan
- Prior art keywords
- bacterial composition
- prevotella histicola
- subject
- total cells
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962883085P | 2019-08-05 | 2019-08-05 | |
| US62/883,085 | 2019-08-05 | ||
| US201962883943P | 2019-08-07 | 2019-08-07 | |
| US62/883,943 | 2019-08-07 | ||
| US201962930370P | 2019-11-04 | 2019-11-04 | |
| US62/930,370 | 2019-11-04 | ||
| US201962940005P | 2019-11-25 | 2019-11-25 | |
| US62/940,005 | 2019-11-25 | ||
| US202063023559P | 2020-05-12 | 2020-05-12 | |
| US63/023,559 | 2020-05-12 | ||
| US202063030581P | 2020-05-27 | 2020-05-27 | |
| US63/030,581 | 2020-05-27 | ||
| PCT/US2020/044851 WO2021026130A1 (en) | 2019-08-05 | 2020-08-04 | Compositions and methods of treating psoriasis and atopic dermatitis using prevotella histicola |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543817A JP2022543817A (ja) | 2022-10-14 |
| JPWO2021026130A5 true JPWO2021026130A5 (zh) | 2023-08-15 |
Family
ID=72179216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507374A Pending JP2022543817A (ja) | 2019-08-05 | 2020-08-04 | プレボテラ・ヒスチコラ（Ｐｒｅｖｏｔｅｌｌａ ｈｉｓｔｉｃｏｌａ）を使用して乾癬及びアトピー性皮膚炎を処置する組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220339208A1 (zh) |
| EP (1) | EP4010077A1 (zh) |
| JP (1) | JP2022543817A (zh) |
| KR (1) | KR20220044315A (zh) |
| CN (1) | CN115515610A (zh) |
| AU (1) | AU2020324970A1 (zh) |
| BR (1) | BR112022002150A2 (zh) |
| CA (1) | CA3150041A1 (zh) |
| CO (1) | CO2022002413A2 (zh) |
| MX (1) | MX2022001607A (zh) |
| TW (1) | TW202120110A (zh) |
| WO (1) | WO2021026130A1 (zh) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US20230019986A1 (en) * | 2020-02-26 | 2023-01-19 | Evelo Biosciences, Inc. | Compositions and methods for reducing cytokine expression |
| TW202227110A (zh) * | 2020-09-21 | 2022-07-16 | 美商艾弗洛生物科技股份有限公司 | 用棲組織普雷沃菌調節免疫反應之組成物及方法 |
| EP4267154A1 (en) * | 2020-12-22 | 2023-11-01 | Evelo Biosciences, Inc. | Compositions comprising animal hemoglobin |
| WO2022187064A1 (en) * | 2021-03-01 | 2022-09-09 | Evelo Biosciences, Inc. | Compositions and methods of treating inflammation using prevotella histicola |
| WO2023062422A1 (en) * | 2021-10-11 | 2023-04-20 | Vastu Vihar Biotech Private Limited | An anti-inflammatory composition and a method of obtaining the same |
| WO2023200837A1 (en) * | 2022-04-13 | 2023-10-19 | Evelo Biosciences, Inc. | Compositions and methods of treating inflammation using prevotella histicola |
| WO2023224372A1 (ko) * | 2022-05-16 | 2023-11-23 | 국민대학교 산학협력단 | 프레보텔라 히스티콜라 |
| CN115631871B (zh) * | 2022-12-22 | 2023-03-24 | 北京大学第三医院（北京大学第三临床医学院） | 一种药物相互作用等级的确定方法和装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8617536B2 (en) * | 2009-10-30 | 2013-12-31 | Mayo Foundation For Medical Education And Research | Prevotella histicola preparations and the treatment of autoimmune conditions |
| US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| MA50087A (fr) * | 2017-09-08 | 2020-07-15 | Evelo Biosciences Inc | Vésicules extracellulaires provenant de prevotella |
| JP7369690B2 (ja) * | 2017-09-08 | 2023-10-26 | エヴェロ バイオサイエンシズ，インコーポレーテッド | 細菌の細胞外小胞 |
-
2020
- 2020-08-04 WO PCT/US2020/044851 patent/WO2021026130A1/en unknown
- 2020-08-04 KR KR1020227007202A patent/KR20220044315A/ko unknown
- 2020-08-04 CA CA3150041A patent/CA3150041A1/en active Pending
- 2020-08-04 CN CN202080056390.8A patent/CN115515610A/zh active Pending
- 2020-08-04 EP EP20760666.6A patent/EP4010077A1/en active Pending
- 2020-08-04 BR BR112022002150A patent/BR112022002150A2/pt not_active Application Discontinuation
- 2020-08-04 JP JP2022507374A patent/JP2022543817A/ja active Pending
- 2020-08-04 US US17/633,105 patent/US20220339208A1/en active Pending
- 2020-08-04 AU AU2020324970A patent/AU2020324970A1/en not_active Abandoned
- 2020-08-04 MX MX2022001607A patent/MX2022001607A/es unknown
- 2020-08-05 TW TW109126592A patent/TW202120110A/zh unknown
-
2022
- 2022-02-28 CO CONC2022/0002413A patent/CO2022002413A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021026130A5 (zh) | ||
| CA2301907A1 (en) | Treatment of cell-mediated immune diseases | |
| CN105582028A (zh) | 樟芝用于治疗疾病的用途 | |
| WO2012090194A2 (en) | Compositions and methods for treating a skin disorder | |
| TWI785178B (zh) | 片仔癀及其製劑在治療帶狀皰疹中的用途 | |
| WO2020010952A1 (zh) | 白芍和铁皮石斛在制备治疗高血压药物中的应用方法 | |
| US20090035401A1 (en) | Composition And Method For Inhibiting Herpesviridae Infections | |
| Craig et al. | Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis | |
| CN1762441A (zh) | 一种治疗高血脂的中药组合物及其制备方法 | |
| CN116870159A (zh) | 一种用于水痘和带状疱疹皮肤病的外用软膏剂及制备方法 | |
| CN108465061B (zh) | 一种用于治疗颜面再发性皮炎的药物组合物及其制备方法和用途 | |
| JP2006515361A (ja) | ヘルペスウイルス感染の症候を治療又は予防する方法 | |
| WO2023036250A1 (zh) | 用于治疗前列腺炎或前列腺增生的药物 | |
| CN103906525B (zh) | 楹树提取物在制备治疗胃溃疡药物中的应用 | |
| US11648240B2 (en) | Pharmaceutical composition comprising famotidine, lidocaine and melatonin | |
| CN108403764B (zh) | 一种用于治疗颜面再发性皮炎的外用制剂及制备方法 | |
| CN114209683A (zh) | 壬二酸在制备治疗炎症性肠病药物中的应用 | |
| CN1223338C (zh) | 盐酸西替利嗪凝胶剂 | |
| CN101757019A (zh) | 用于减肥或治疗代谢综合征的药物组合物 | |
| WO2019128511A1 (zh) | 片仔癀及其制剂在制备治疗带状疱疹后遗神经痛的药物中的用途 | |
| CN1533795A (zh) | 一种治疗消化性溃疡的中药及其制法 | |
| CN1236765C (zh) | 治疗鼻息肉和鼻息肉病的左旋咪唑新剂型 | |
| CN109432082B (zh) | 一种防治化学性肝损伤的药物组合物 | |
| Duan | New Progress in Pharmacodynamics and Application of Lupatadine | |
| JP2002114671A (ja) | サイトカイン産生抑制剤 |